The primary treatment options for chronic lymphocytic leukaemia (CLL) are immunotherapy, targeted therapies and chemotherapy. In many cases, CLL patients may never need treatment as long as you do not experience symptoms. When treatment is needed, the type of treatment you receive will depend on a number of different considerations, such as the stage of your cancer, your overall health and your treatment preferences. This page aims to give you a comprehensive overview of how chronic lymphocytic leukaemia treatment works in Malaysia.
Chronic Lymphocytic Leukaemia
Understanding treatment for chronic lymphocytic leukaemia and how it is delivered
Last modified: March 3, 2022
Chemotherapy for chronic lymphocytic leukaemiaChemotherapy
Chemotherapy is the primary treatment for CLL, which involves the use of a range of drugs to kill and slow the growth of chronic lymphocytic leukaemia cells. Depending on the type of CLL you have and your age, you may have different treatment options.
Chemotherapy drugs for CLL are usually given together in combination with an immunotherapy drug and administered every 28 days for six cycles.
Targeted therapies for chronic lymphocytic leukaemiaTargeted therapies
Targeted therapies use specialised drugs to destroy CLL cells by targeting abnormalities found within cancer cells while avoiding normal, healthy cells. Targeted therapies are the preferred treatment for people with CLL with genetic changes known as TP53 mutation or 17p deletion.
Immunotherapy for acute lymphoblastic leukaemiaImmunotherapy
Immunotherapy trains your body’s own immune system to recognise and fight chronic lymphocytic leukaemia cells.
Monoclonal antibody drugs are a type of immunotherapy treatment which target a protein called CD20 on the surface of certain white blood cells called B-lymphocytes (B-cells). When they attach to the CD20 protein, which are present on the B cells of people with chronic lymphocytic leukaemia, this allows your own immune system to recognise and target cancer cells and destroy them.
When you are diagnosed with CLL, your haematologist will develop your treatment plan as part of a multidisciplinary team based on the stage of your cancer. In many cases, CLL patients may never need treatment as long as they do not experience symptoms. Common treatment options for each stage of CLL include:
-
Stage 0 chronic lymphocytic leukaemia
While CLL is in stage 0, lymphocyte levels in your blood are high but no other symptoms of leukaemia are present. No treatment is typically need at this stage and your haematologist will likely recommend active monitoring.
-
Stage I chronic lymphocytic leukaemia
Stage I CLL is similar to stage 0 as lymphocyte levels are high, although lymph nodes may be larger than normal. Again, no treatment is typically needed at this stage.
-
Stage II chronic lymphocytic leukaemia
In stage II CLL it is also common for the liver and spleen to become swollen, alongside elevated lymphocytes in the blood and swollen lymph nodes. Depending on the severity of your symptoms and the level of lymphocytes in your blood, your haematologist may recommend that you begin treatment.
-
Stage III chronic lymphocytic leukaemia
Once CLL reaches stage III, lymphocytes remain elevated and your red blood cell count will have decreased, resulting in anaemia. While platelet counts will remain normal, your disease has reached an advanced and high-risk stage that now requires treatment.
The first step in treatment for CLL is to lower lymphocyte levels which can be done in a number of ways. Some options include chemotherapy, targeted therapy, immunotherapy or a combination of these. Very rarely you may need leukapheresis treatment, which involves passing your blood through a machine to remove white blood cells and returning the remaining blood back to your body, as increased CLL cells in your blood stream can also cause issues with circulation.
-
Stage IV chronic lymphocytic leukaemia
When CLL progresses to stage IV, all previous symptoms may be present, but platelet levels will have also fallen making it difficult for blood to clot. Similarly to stage III this requires the initiation of treatment.
ReferencesReferences
For a full list of references, click here.
- National Cancer Institute. (2021, September 20). Chronic lymphocytic leukemia treatment. National Cancer Institute. Retrieved December 22, 2021, from https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq
- Leukaemia Foundation. (2020, July 22). Chronic lymphocytic leukaemia (CLL). Leukaemia Foundation. Retrieved December 22, 2021, from https://www.leukaemia.org.au/blood-cancer-information/types-of-blood-cancer/leukaemia/chronic-lymphocytic-leukaemia/
- Leukaemia Foundation. (2020, October 11). Chronic lymphocytic leukemia treatment. Leukaemia Foundation. Retrieved December 22, 2021, from https://www.leukaemia.org.au/blood-cancer-information/types-of-blood-cancer/leukaemia/chronic-lymphocytic-leukaemia/chronic-lymphocytic-leukemia-treatment/
Make An Appointment
We are here to help you navigate this difficult time and to focus on the individual needs of our patients and their families offering both in-person and telemedicine consultations.
Cancer Information Library
A library of articles and resources developed by Icon to help you gain a better understanding of a cancer diagnosis and treatments.
Our doctors
Icon brings together some of Malaysia’s most experienced clinical oncologists, medical oncologists and radiation oncologists.
Families and carers
Helpful information on finding the right support when caring for a loved one with cancer.